Inhibition of matrix metalloproteinases by over-expression of tissue inhibitor of metalloproteinase-2 inhibits the growth of experimental hemangiomas

International Journal of Cancer

Volumn 91, Issue 2, 2001, Pages 241-247

  Vergani, V ^a   Garofalo, A ^b   Bani, M R ^c   Borsotti, P ^b   Parker, M Pelina ^c   Drudis, T ^b   Mazzarol, G ^b   Viale, G ^c   Giavazzi, R ^b   Stetler Stevenson, W G ^a   Taraboletti, G ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Angiogenesis; Endothelial cells; Endothelioma; Matrix metalloproteinases; TIMP 2

Indexed keywords

MATRIX METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL INVASION; CELL MOTILITY; CELL TRANSFORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FEMALE; GENE TRANSFER; HEMANGIOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR GROWTH; ZYMOGRAPHY;

EID: 0035863487     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1035>3.3.CO;2-G     Document Type: Article

References (39)

1. Proteases as prognostic markers in cancer
2. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression
3. Contributions of tumor and stroma matrix metalloproteinases to tumor progression, invasion and metastasis
4. Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutic implications
5. Changing views of the role of matrix metalloproteinases in metastasis
6. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semi-quantitative PCR-based assay
7. ECM and cell surface proteolysis: Regulating cellular ecology
8. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
9. Matrix metalloproteinases
10. Proteases and protease inhibitors in tumor progression
11. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis
12. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: Inhibition of KS-like lesions by tissue inhibitor if metalloproteinase-2
13. Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2)
14. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases
15. Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP-1 and TIMP-2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma
16. TIMP-2 expression modulates human melanoma cell adhesion and motility
17. Effect of tissue inhibitor of metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line
18. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2
19. Over-expression of tissue inhibitor of metalloproteinases-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion
20. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment
21. Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene
22. Endothelial cell migration and invasiveness are induced by a soluble factor produced by murine endothelioma cells transformed by polyoma virus middle T oncogene
23. Cellular markers that distinguish the phases of hemangiomas during infancy and childhood
24. Endothelial cells transformed by polyomavirus middle-T oncogene: A model for hemangiomas and other vascular tumours
25. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases
26. Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells
27. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies
28. Tumor cell invasion inhibited by TIMP-2
29. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation
30. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene
31. Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle T: Implications for the pathogenesis of opportunistic vascular tumors
32. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 over-expression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro
33. TIMP-2 growth-stimulatory activity: A concentration- and cell type-specific response in the presence of insulin
34. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity
35. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
36. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by over-expression of TIMP-3
37. Tissue inhibitor of matrix metalloproteinases-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros
38. Angiostatin induces and sustains dormancy of human primary tumors in mice
39. BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity